Visium Asset Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Visium Asset Management’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-16,995	Closed	-$252K	–	681
2015 Q4	$252K	Sell	16,995 -5,381,093	-100%	-$90M	﹤0.01%	549
2015 Q3	$88.6M	Buy	5,398,088 +1,256,988	+30%	+$25.7M	1.21%	11
2015 Q2	$94.5M	Buy	4,141,100 +2,761,090	+200%	+$55M	1.34%	10
2015 Q1	$21M	Buy	1,380,010 +599,861	+77%	+$7.79M	0.31%	64
2014 Q4	$9.39M	Buy	780,149 +438,149	+128%	+$5.01M	0.13%	139
2014 Q3	$3.88M	Buy	+342,000	New	+$3.9M	0.06%	327
2014 Q1	–	Sell	-3,620,000	Closed	-$64M	–	1080
2013 Q4	$64M	Buy	3,620,000 +2,820,000	+353%	+$47.4M	1.26%	13
2013 Q3	$11.5M	Sell	800,000 -4,250,000	-84%	-$65M	0.26%	73
2013 Q2	$76.1M	Buy	+5,050,000	New	+$66.6M	1.78%	11

Other funds holding MNTA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

DCM

Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACM

Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Visium Asset Management's MNTA Position: Q1 2016 in Review

Visium Asset Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q1 2016, closing a stake of 16,995 shares — an estimated $252K sold.

Visium Asset Management first reported a position in MNTA in Q2 2013 and held it in 9 quarters. The position peaked at $94.5M in Q2 2015. 148 funds tracked by Wall St. Rank hold MNTA as of Q1 2016.

Visium Asset Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
Visium Asset Management sold 16,995 Momenta Pharmaceuticals, Inc. shares in Q1 2016, an estimated $252K.
Visium Asset Management first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 9 quarters.
Visium Asset Management's Momenta Pharmaceuticals, Inc. position peaked at $94.5M in Q2 2015.
148 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q1 2016.

Based on Visium Asset Management's 13F filing for Q1 2016, filed 16 May 2016.